GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acasti Pharma Inc (TSXV:ACST) » Definitions » Price-to-Funds-From-Operations

Acasti Pharma (TSXV:ACST) Price-to-Funds-From-Operations : (As of Apr. 28, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Acasti Pharma Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Acasti Pharma Business Description

Industry
Traded in Other Exchanges
Address
103 Carnegie Center, Suite 300, Princeton, NJ, USA, 08540
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
Executives
Donald John Olds Director
Jean-françois Boily Senior Officer
Jean-marie Canan Director